Literature DB >> 2851313

Serum hyaluronic acid levels in cancer.

E H Cooper1, M A Forbes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2851313      PMCID： PMC2246812          DOI： 10.1038/bjc.1988.283

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

1.  Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.

Authors:  A Engström-Laurent; R Hällgren
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

2.  Wilms' tumor clinical correlation with circulating mucin in three cases.

Authors:  D R Powars; S E Allerton; J Beierle; B B Butler
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

3.  Hyperviscosity caused by hyaluronic acid in serum in a case of Wilms' tumor.

Authors:  A H Wu; O S Parker; L Ford
Journal:  Clin Chem       Date:  1984-06       Impact factor: 8.327

4.  Poor prognosis for mucin-producing Wilms' tumor.

Authors:  J L Ater; W M Gooch; B L Bybee; R T O'Brien
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

5.  Quantitative analysis of hyaluronate in nanogram amounts.

Authors:  A Tengblad
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

6.  Determination of hyaluronate in biological samples by a specific radioassay technique.

Authors:  U B Laurent; A Tengblad
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

7.  Mucopolysaccharide in the blood of a patient with neuroblastoma.

Authors:  P M Broughton; J R Dykes; S Holt; J W Ridley; A E Steel
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

8.  Increased serum levels of hyaluronate in liver disease.

Authors:  A Engström-Laurent; L Lööf; A Nyberg; T Schröder
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

9.  Concentration of sodium hyaluronate in serum.

Authors:  A Engström-Laurent; U B Laurent; K Lilja; T C Laurent
Journal:  Scand J Clin Lab Invest       Date:  1985-10       Impact factor: 1.713

10.  Immunoenzymoassay of the hyaluronic acid-hyaluronectin interaction: application to the detection of hyaluronic acid in serum of normal subjects and cancer patients.

Authors:  B Delpech; P Bertrand; C Maingonnat
Journal:  Anal Biochem       Date:  1985-09       Impact factor: 3.365
View more
  3 in total

1.  In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties.

Authors:  A Luquita; L Urli; M J Svetaz; A M Gennaro; M E Giorgetti; G Pistone; R Volpintesta; S Palatnik; M Rasia
Journal:  J Biomed Sci       Date:  2010-02-12       Impact factor: 8.410

2.  Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.

Authors:  K Beckenlehner; S Bannke; T Spruss; G Bernhardt; H Schönenberg; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.

Authors:  Toshifumi Matsuyama; Steven K Yoshinaga; Kimitaka Shibue; Tak W Mak
Journal:  Cell Death Differ       Date:  2021-10-18       Impact factor: 15.828
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.